Effect of intracoronary nitroglycerin and verapamil on coronary blood flow in patients with slow flow coronary arteries

Effect of intracoronary nitroglycerin and verapamil on coronary blood flow in coronary slow flow patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200102045983N1

Enrollment

Registered

2020-11-05

Start date

2019-12-22

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

slow flow coronary artery.

Interventions

Intervention 1: intervention group 1 :During angiography in slow flow coronary artery patients,50 micro grams nitroglycerin or 100 micro grams verapamil is injected in standard view for each coronary

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with diagnosis of coronary slow flow based on TIMI Frame Count calculation

Exclusion criteria

Exclusion criteria: History of angioplasty , coronary artery bypass graft surgery and any intervention on coronary arteries

Design outcomes

Primary

Measure	Time frame
Change in TIMI Frame Count after intracoronary verapamil or nitroglycerin injection. Timepoint: TIMI Frame count measurement before and immediately after intracoronary injection of verapamil and nitroglycerin. Method of measurement: TIMI Frame Count in number.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mehdi Sheibani

Shahid Beheshti University of Medical Sciences

mesheibani@yahoo.com+98 21 2208 3106

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026